Gene expression profiling has successfully classified muscle-invasive bladder cancer (MIBC) tumors into distinct categories that differ in their genetic characteristics and tumor mutation burden (TMB). In addition to cancer-cell autonomous factors, the tumor microenvironment (TME) is a known key player in therapy response. The relationship between TME and different MIBC molecular subtypes is understudied.